title: NIA commentary: translational issues in Alzheimer's disease drug development.
authors.affiliation: Division of Neuroscience, National Institute on Aging, Bethesda, MD 20892, USA. buckholn@nia.nih.gov
authors.forename: Neil S
authors.initials: NS
authors.lastname: Buckholtz
authors.forename: Laurie M
authors.initials: LM
authors.lastname: Ryan
authors.forename: Suzana
authors.initials: S
authors.lastname: Petanceska
authors.forename: Lorenzo M
authors.initials: LM
authors.lastname: Refolo
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D015195:Drug Design; D006801:Humans; D054561:National Institute on Aging (U.S.) / Q000639:trends*; D009480:Neuropharmacology / Q000639:trends*; D057170:Translational Research, Biomedical / Q000639:trends*; D014481:United States